Depression News and Research

Latest Depression News and Research

Natural painkiller system in the brain responds to social rejection

"Sticks and stones may break my bones, but words will never hurt me," goes the playground rhyme that's supposed to help children endure taunts from classmates. But a new study suggests that there's more going on inside our brains when someone snubs us - and that the brain may have its own way of easing social pain.

11 Oct 2013

Study assesses risk of psychiatric events in patients prescribed smoking cessation drugs

A study to assess whether patients prescribed smoking cessation drugs are at an increased risk of suicide, self-harm and treated depression compared with users of nicotine replacement therapy has found no evidence of an increased risk.

11 Oct 2013

Crucial role of orthopedic surgeons in diagnosing mTBI among trauma care patients

In the United States, approximately 1.4 million people suffer a traumatic brain injury (TBI) each year. Of those injuries, three out of four are minor TBI (mTBI)-a head injury that causes a temporary change in mental status including confusion, an altered level of consciousness, or perceptual or behavioral impairments.

11 Oct 2013

Depression in Parkinson's disease people associated with reduced dopamine synthesis capacity

According to the Parkinson's Disease Foundation, up to 60% of individuals with Parkinson's disease exhibit mild to moderate depression, which is often underdiagnosed. It is unclear whether depression results from having a debilitating disease or reflects a parallel abnormal change in the brain caused by PD pathophysiology.

11 Oct 2013

People who live in coal mining regions face increased risk depression

People who live among the destructive environmental effects of mountaintop coal mining face an increased risk of major depression. The results of a study conducted in the coal mining regions of Central Appalachia that explored the relationship between psychological health and environmental degradation are published in Ecopsychology, a peer-reviewed, online journal from Mary Ann Liebert, Inc., publishers.

11 Oct 2013

Alkermes' ALKS 5461 drug gets FDA Fast Track status for major depressive disorder

Alkermes plc today announced that the U.S. Food and Drug Administration has granted Fast Track status for ALKS 5461 for the adjunctive treatment of major depressive disorder in patients with an inadequate response to standard therapies.

10 Oct 2013

Transcendental Meditation technique has large effect on reducing trait anxiety, shows analysis

A new meta-analysis published today in the Journal of Alternative and Complementary Medicine (2013;19(10):1-12)1 found the Transcendental Meditation- technique (TM) has a large effect on reducing trait anxiety for people with high anxiety.

10 Oct 2013

Lundbeck, Otsuka to continue development of Lu AE58054 compound for Alzheimer's disease

H. Lundbeck A/S and Otsuka Pharmaceutical Co., Ltd. announced today the continuation of the development program of Lu AE58054 for the treatment of Alzheimer's disease, initiating the first out of four phase III clinical trials with the compound.

10 Oct 2013

TSRI scientists identify set of compounds to treat multiple sclerosis in new way

Scientists at The Scripps Research Institute (TSRI) have identified a set of compounds that may be used to treat multiple sclerosis (MS) in a new way. Unlike existing MS therapies that suppress the immune system, the compounds boost a population of progenitor cells that can in turn repair MS-damaged nerve fibers.

10 Oct 2013

Risk of dying from invasive breast cancer lower among multivitamin/mineral users

Findings from a study involving thousands of postmenopausal women suggest that women who develop invasive breast cancer may benefit from taking supplements containing both multivitamins and minerals.

9 Oct 2013

Alkermes announces plans to advance ALKS 5461 phase 3 program for major depressive disorder

Alkermes plc today announced that it has successfully completed its End-of-Phase 2 interactions with the U.S. Food and Drug Administration (FDA), and the company plans to advance ALKS 5461 into phase 3 development in early 2014.

9 Oct 2013

BUSM researchers develop screening tool to detect intimate partner violence in females

Boston University School of Medicine (BUSM) researchers have identified a promising screening tool to detect intimate partner violence (IPV) in females in the VA Boston Healthcare System.

9 Oct 2013

UCLA investigates high rates of schizophrenia in people with 22q11.2 deletion syndrome

UCLA has joined an international consortium to investigate the high rates of schizophrenia and other neuropsychiatric disorders in those who are affected with Chromosome 22q11.2 deletion syndrome, a disorder caused by the deletion of a small piece of chromosome number 22.

9 Oct 2013

Alkermes completes patient enrollment in phase 3 study of aripiprazole lauroxil in schizophrenia patients

Alkermes plc (NASDAQ: ALKS) today announced completion of patient enrollment in the pivotal, multinational phase 3 study evaluating aripiprazole lauroxil in patients with schizophrenia.

9 Oct 2013

Bipolar disorder ‘distinct’ from borderline personality disorder

Researchers say that there are clear clinical differences between depressed patients with bipolar II disorder and those with borderline personality disorder, which supports the two being treated as distinct conditions.

8 Oct 2013

Short sleep duration linked to suicidal ideation

Short sleep duration is associated with an increased risk for suicidal ideation, a cross-sectional study of Korean adults shows.

8 Oct 2013

Depression impairs sleep in breast cancer, but being married helps

Women with metastatic breast cancer are more likely to experience sleep disturbances if they are depressed or single, researchers report.

8 Oct 2013

Retirement a sticking point for antihypertensive adherence

Patients’ adherence to their antihypertensive medication may decline when they retire from work, a study shows.

8 Oct 2013

Brain & Behavior Research Foundation to hold research symposium on mental health

The Brain & Behavior Research Foundation, an organization dedicated to improving the lives of those with mental illness through the transformative power of neuroscience and psychiatric research, will hold its 25th Annual Mental Health Research Symposium on Friday, October 25th from 9:00 am to 4:30 p.m. at the Kaufman Music Center, located at 129 W. 67th St. in New York City.

8 Oct 2013

Publication provides update on the origins and causes of anxiety disorders

Anxiety disorders are not uncommon and are often 'comorbid' with other forms of mental disorders. This publication provides an update on the origins and the causes of anxiety disorders and their related symptoms.

8 Oct 2013

Depression News and Research

Latest Depression News and Research

Natural painkiller system in the brain responds to social rejection

Study assesses risk of psychiatric events in patients prescribed smoking cessation drugs

Crucial role of orthopedic surgeons in diagnosing mTBI among trauma care patients

Depression in Parkinson's disease people associated with reduced dopamine synthesis capacity

People who live in coal mining regions face increased risk depression

Alkermes' ALKS 5461 drug gets FDA Fast Track status for major depressive disorder

Transcendental Meditation technique has large effect on reducing trait anxiety, shows analysis

Lundbeck, Otsuka to continue development of Lu AE58054 compound for Alzheimer's disease

TSRI scientists identify set of compounds to treat multiple sclerosis in new way

Risk of dying from invasive breast cancer lower among multivitamin/mineral users

Alkermes announces plans to advance ALKS 5461 phase 3 program for major depressive disorder

BUSM researchers develop screening tool to detect intimate partner violence in females

UCLA investigates high rates of schizophrenia in people with 22q11.2 deletion syndrome

Alkermes completes patient enrollment in phase 3 study of aripiprazole lauroxil in schizophrenia patients

Bipolar disorder ‘distinct’ from borderline personality disorder

Short sleep duration linked to suicidal ideation

Depression impairs sleep in breast cancer, but being married helps

Retirement a sticking point for antihypertensive adherence

Brain & Behavior Research Foundation to hold research symposium on mental health

Publication provides update on the origins and causes of anxiety disorders

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Depression News and Research

Latest Depression News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in